Lexington Biosciences Announces Appointment of CEO
April 16, 2020 18:29 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, April 16, 2020 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (the “Company” or “Lexington”) is pleased to announce the appointment of Donald McInnes as...
Lexington Biosciences Provides Corporate Update
February 20, 2020 14:16 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (the “Company” or “Lexington”) provides the following corporate update to shareholders. ...
Lexington Biosciences License Terminated
February 12, 2020 21:13 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (the “Company” or “Lexington”) has allowed the license with the Lawrence Berkeley National...
Lexington Biosciences Converts Amounts Owed to Unsecured Demand Loans
October 04, 2019 15:28 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (the “Company” or “Lexington”) announces that it has reached agreement with third parties as...
Lexington Biosciences to Consolidate its Common Shares
April 25, 2019 08:00 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, April 25, 2019 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”) announces that effective at the opening of...
Lexington Biosciences Provides Update on Financial Situation
April 02, 2019 04:00 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, April 02, 2019 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”) announced on February 14, 2019 that it had been...
Lexington Biosciences Announces Termination of Private Placement
February 14, 2019 17:05 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”) announces that, despite numerous attempts over the...
Lexington Announces Q3 2018 Financial Results and Non-Brokered Private Placement
November 29, 2018 23:46 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”) announces the release of the Company’s Condensed...
Lexington Provides Q3 Corporate Review
October 23, 2018 18:37 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
Lexington Announces Non-Brokered Private Placement
August 27, 2018 09:00 ET
|
Lexington Biosciences, Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, British Columbia, Aug. 27,...